• Bristol Myers pulls Opdivo for use in liver cancer amid broader FDA scrutiny of speedy approvals

    2 monthes ago - By MedCity News

    Bristol Myers Squibb blockbuster drug Opdivo is being pulled from the market after failing to meet the main goal of a confirmatory study. The voluntary withdrawal comes amid broader FDA scrutiny of cancer drugs that were given accelerated approval.
    Read more ...